Simultaneous Determination of Cocaine, Cocaethylene, and Their December 2003 Possible Pentafluoropropylated Metabolites and Pyrolysis Products by 6

Total Page:16

File Type:pdf, Size:1020Kb

Simultaneous Determination of Cocaine, Cocaethylene, and Their December 2003 Possible Pentafluoropropylated Metabolites and Pyrolysis Products by 6 DOT/FAA/AM-03/24 Simultaneous Determination of Cocaine, Office of Aerospace Medicine Cocaethylene, and Their Possible Washington, DC 20591 Pentafluoropropylated Metabolites and Pyrolysis Products by Gas Chromatography/Mass Spectrometry Patrick S. Cardona Arvind K. Chaturvedi John W. Soper Dennis V. Canfield Civil Aerospace Medical Institute Federal Aviation Administration Oklahoma City, OK 73125 December 2003 Final Report This document is available to the public through the National Technical Information Service, Springfield, VA 22161. NOTICE This document is disseminated under the sponsorship of the U.S. Department of Transportation in the interest of information exchange. The United States Government assumes no liability for the contents thereof. Technical Report Documentation Page 1. Report No. 2. Government Accession No. 3. Recipient's Catalog No. DOT/FAA/AM-03/24 4. Title and Subtitle 5. Report Date Simultaneous Determination of Cocaine, Cocaethylene, and Their December 2003 Possible Pentafluoropropylated Metabolites and Pyrolysis Products by 6. Performing Organization Code Gas Chromatography/Mass Spectrometry 7. Author(s) 8. Performing Organization Report No. Cardona PS, Chaturvedi AK, Soper JW, Canfield DV 9. Performing Organization Name and Address 10. Work Unit No. (TRAIS) FAA Civil Aerospace Medical Institute P.O. Box 25082 11. Contract or Grant No. Oklahoma City, OK 73125 12. Sponsoring Agency Name and Address 13. Type of Report and Period Covered Office of Aerospace Medicine Federal Aviation Administration 800 Independence Ave., S.W. Washington, DC 20591 14. Sponsoring Agency Code 15. Supplemental Notes This work was accomplished under the approved tasks AM-B-98-TOX-202, AM-B-99-TOX-202, AM-B-00- TOX-202, AM-B-01-TOX-202, AM-B-02-TOX-202, and AM-B-03-TOX-202. 16. Abstract During the investigations of fatal transportation accidents, samples from victims are also analyzed for drugs, including cocaine (COC). COC is abused by smoking, nasal insufflantion, and intravenous injection, and it is also taken with ethanol. Therefore, it is important to determine concentrations of COC and its metabolites, ethanol analogs, and pyrolysis products for establishing the degree of toxicity, the possible ingestion of ethanol, and the possible route of administration. In this study, a sensitive and selective procedure is developed for the simultaneous analyses of COC, benzoylecgonine, norbenzoylecgonine, norcocaine, ecgonine, ecgonine methyl ester, m-hydroxybenzoylecgonine, anhydroecgonine methyl ester (AEME), anhydroecgonine (AECG), cocaethylene, norcocaethylene, and ecgonine ethyl ester in blood, urine, and muscle homogenate. In the analysis, available deuterated analogs of these analytes were used as internal standards. Proteins from blood and muscle homogenate were precipitated with cold acetonitrile. After the removal of acetonitrile by evaporation, the supernatants and urine were extracted by solid-phase chromatography. The eluted analytes were converted to hydrochloride salts and derivatized with pentafluoropropionic anhydride and 2,2,3,3,3-pentafluoro-1-propanol. The derivatized products were analyzed on a gas chromatograph (GC)/mass spectrometer system by selected ion monitoring. This method was successfully applied in analyzing 13 case specimens from aviation accident pilot fatalities and/or motor vehicle operators. AEME concentrations found in the 13 specimens were consistent with those produced solely by the GC inlet pyrolysis of COC controls, suggesting that COC was not abused in these cases by smoking. Although AEME remains a potential marker for establishing the abuse of COC by smoking, AECG was not a useful marker because of its low recovery and GC inlet production from COC metabolites. The developed procedure is unique because multiple analytes can be analyzed in urine, blood, and solid tissues by a single extraction with increased sensitivity through formation of hydrochloride salts and using a one-step derivatization. 17. Key Words 18. Distribution Statement Forensic Sciences, Toxicology, Cocaine, Metabolites, Document is available to the public through the Pyrolysis Products, Analysis, Gas Chromatography/ National Technical Information Service Mass Spectrometry Springfield, Virginia 22161 19. Security Classif. (of this report) 20. Security Classif. (of this page) 21. No. of Pages 22. Price Unclassified Unclassified 19 Form DOT F 1700.7 (8-72) Reproduction of completed page authorized i LIST OF ABBREVIATIONS AECG _ _ _ _ _ _ _ anhydroecgonine AEME _ _ _ _ _ _ _ anhydroecgonine methyl ester BEG _ _ _ _ _ _ _ _ benzoylecgonine BEG-D3 _ _ _ _ _ _ _ benzoylecgonine-D3 CAMI _ _ _ _ _ _ _ _ Civil Aerospace Medical Institute COE _ _ _ _ _ _ _ _ cocaethylene COE-D3 _ _ _ _ _ _ _ cocaethylene-D3 COC _ _ _ _ _ _ _ _ cocaine COC-D3 _ _ _ _ _ _ _ cocaine-D3 CYP _ _ _ _ _ _ _ _ cytochrome P-450 ECG _ _ _ _ _ _ _ _ ecgonine EEE _ _ _ _ _ _ _ _ ecgonine ethyl ester EME _ _ _ _ _ _ _ _ ecgonine methyl ester EME-D3 _ _ _ _ _ _ _ ecgonine methyl ester-D3 FAA _ _ _ _ _ _ _ _ Federal Aviation Administration GC/MS _ _ _ _ _ _ _ gas chromatograph/mass spectrometer HBEG _ _ _ _ _ _ _ m-hydroxybenzoylecgonine LOD _ _ _ _ _ _ _ _ limit of detection LOQ _ _ _ _ _ _ _ _ limit of quanititation NBEG _ _ _ _ _ _ _ norbenzoylecgonine NCOE _ _ _ _ _ _ _ norcocaethylene NCOC _ _ _ _ _ _ _ norcocaine NCOC-D3 _ _ _ _ _ _ norcocaine-D3 OSBI _ _ _ _ _ _ _ _ Oklahoma State Bureau of Investigation PFP _ _ _ _ _ _ _ _ pentafluoropropylated PFPA _ _ _ _ _ _ _ _ pentafluoropropionic anhydride PFPOH _ _ _ _ _ _ _ 2,2,3,3,3-pentafluoro-1-propanol SIM _ _ _ _ _ _ _ _ selected ion monitoring SPE _ _ _ _ _ _ _ _ _ solid phase extraction. iii SIMULTANEOUS DETERMINATION OF COCAINE, COCAETHYLENE, AND THEIR POSSIBLE PENTAFLUOROPROPYLATED METABOLITES AND PYROLYSIS PRODUCTS BY GAS CHROMATOGRAPHY/MASS SPECTROMETRY INTRODUCTION conversion of COC into EME and BEG (Fig. 1). Even The Federal Aviation Administration’s (FAA’s) Civil in water, at pH values greater than neutrality, COC is Aerospace Medical Institute (CAMI) is involved in the readily hydrolyzed to BEG. Cholinesterases in blood toxicological evaluation of samples collected from victims hydrolyze COC into EME, but this enzymatic reaction involved in fatal transportation accidents. During the may be inhibited by freezing or by the addition of fluoride investigations of such accidents, those biological samples or cholinesterase inhibitors (9, 10, 11). A considerable are analyzed for the presence of combustion gases (car- amount of time may often pass before postmortem speci- bon monoxide and hydrogen cyanide), alcohol and other mens are collected, chemically preserved, and refriger- volatiles, and drugs, including cocaine (COC). COC, a ated. Such a delay may possibly cause the conversion of popular drug of abuse, is consumed by smoking, nasal all or some COC and COE into EME, BEG, and/or insufflation, and intravenous injection (1). COC is also EEE. Therefore, concentrations of COC, COE, EME, often taken in conjunction with ethanol, generating a BEG, other possible metabolites, and pyrolysis products transesterification product, cocaethylene (COE; 2). This in biological samples could be helpful in estimating the COC analog has pharmacological activities similar to total amount of COC present in those samples at the COC and may modestly prolong the COC-like effects time of their collection and/or at the time of an accident (3). In recreational use, smoking may be the preferred and/or death. Furthermore, the concentrations of COE, route of ingestion of COC because its effects are immedi- NCOE, and EEE may indicate concurrent use of COC ate and intense. Furthermore, such effects are achieved and ethanol, and the concentration of AEME may assist without having to deal with needles and syringes, thereby in establishing whether COC was smoked or taken by minimizing the risk of contracting bloodborne diseases. other routes. Free-base COC (crack) is generally associated with smok- Numerous analytical methods for COC, COE, their ing (1, 4, 5), while its salt form may be associated with metabolites, and other related products are reported in the other routes of administration. literature (5, 7, 12, 13), but these methods involve mul- Peak COC concentrations in blood usually occur tiple extraction and/or derivatization procedures and/or 30–60 min after nasal insufflation and within minutes have not been shown to detect all the COC and possible after smoking or intravenous injection ingestion (6). related analytes in multiple specimen types. Although the COC is rapidly inactivated by the hydrolysis of its ester pyrolytic product of COC, AEME, has been analyzed groups, producing benzoylecgonine (BEG), ecgonine in blood, serum, and urine (5, 7, 12, 13), it has been methyl ester (EME), and possibly ecgonine (ECG; Fig. demonstrated that COC can thermally degrade during 1). COC is further biotransformed by the cytochrome gas chromatography, particularly at high injector port P-450 (CYP) enzyme system to norcocaine (NCOC), and temperatures (8, 14). BEG to norbenzoylecgonine (NBEG) and m-hydroxyben- In the present study, a selective and sensitive method, zoylecgonine (HBEG). Smoking produces the pyrolysis involving a single extraction and derivatization, was de- product anhydroecgonine methyl ester (AEME; 7, 8), veloped to simultaneously analyze COC, COE, their me- which could be further hydrolyzed to anhydroecgonine tabolites and pyrolysis products, and related compounds (AECG). Furthermore, COE is metabolized into norco- by gas chromatography/mass spectrometry in blood, urine, caethylene (NCOE) and hydrolyzed into ecgonine ethyl and solid tissues. Attempts were also made to establish ester (EEE), which could also be biosynthesized from EME a relationship between the concentration of COC and in the presence of ethanol.
Recommended publications
  • Recommended Methods for the Identification and Analysis of Fentanyl and Its Analogues in Biological Specimens
    Recommended methods for the Identification and Analysis of Fentanyl and its Analogues in Biological Specimens MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Fentanyl and its Analogues in Biological Specimens MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS Vienna, 2017 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases. However, any modification has to be validated before it is integrated into laboratory routines. ST/NAR/53 Original language: English © United Nations, November 2017. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Acknowledgements The Laboratory and Scientific Section of the UNODC (LSS, headed by Dr. Justice Tettey) wishes to express its appreciation and thanks to Dr. Barry Logan, Center for Forensic Science Research and Education, at the Fredric Rieders Family Founda- tion and NMS Labs, United States; Amanda L.A.
    [Show full text]
  • Cocaine: Pharmacology, Effects, and Treatment of Abuse
    Cocaine: Pharmacology, Effects, and Treatment of Abuse U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Cocaine: Pharmacology, Effects, and Treatment of Abuse Editor: John Grabowski, Ph.D. Division of Clinical Research National Institute on Drug Abuse NIDA Research Monograph 50 1984 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY, COHEN M.D. Temple University School of Medicine LosAngeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic Institute National Federation of Parents for Troy, New York Drug Free Youth RICHARD BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTMAN Langley Porter Neuropsychiatric Institute San Francisco, California Alcohol and Drug Problems Association of North America Washington, D.C. DENISE KANDEL, Ph.D. GILBERT J. BOVTIN, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.
    [Show full text]
  • List of Narcotic Drugs Under International Control
    International Narcotics Control Board Yellow List Annex to Forms A, B and C 59th edition, July 2020 LIST OF NARCOTIC DRUGS UNDER INTERNATIONAL CONTROL Prepared by the INTERNATIONAL NARCOTICS CONTROL BOARD* Vienna International Centre P.O. Box 500 A-1400 Vienna, Austria Internet address: http://www.incb.org/ in accordance with the Single Convention on Narcotic Drugs, 1961** Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 * On 2 March 1968, this organ took over the functions of the Permanent Central Narcotics Board and the Drug Supervisory Body, r etaining the same secretariat and offices. ** Subsequently referred to as “1961 Convention”. V.20-03697 (E) *2003697* Purpose The Yellow List contains the current list of narcotic drugs under international control and additional relevant information. It has been prepared by the International Narcotics Control Board to assist Governments in completing the annual statistical reports on narcotic drugs (Form C), the quarterly statistics of imports and exports of narcotic drugs (Form A) and the estimates of annual requirements for narcotic drugs (Form B) as well as related questionnaires. The Yellow List is divided into four parts: Part 1 provides a list of narcotic drugs under international control in the form of tables and is subdivided into three sections: (1) the first section includes the narcotic drugs listed in Schedule I of the 1961 Convention as well as intermediate opiate raw materials; (2) the second section includes the narcotic drugs listed in Schedule II of the 1961 Convention; and (3) the third section includes the narcotic drugs listed in Schedule IV of the 1961 Convention.
    [Show full text]
  • Recommended Methods for the Identification and Analysis of Cocaine in Seized Materials
    Recommended methods for the Identification and Analysis of Cocaine in Seized Materials MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Photo credits: UNODC Photo Library; UNODC/Ioulia Kondratovitch; Alessandro Scotti. Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Cocaine in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS New York, 2012 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases, but any modification has to be validated before it is integrated into laboratory routines. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. ST/NAR/7/REV.1 Original language: English © United Nations, March 2012. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. ii Contents Page 1. Introduction ................................................. 1 1.1 Background .............................................. 1 1.2 Purpose and use of the manual .............................. 1 2. Physical appearance and chemical characteristics of coca leaf and illicit materials containing cocaine ................................
    [Show full text]
  • Cocaine/Benzoylecgonine-2 Elisa Kit Instructions Product #130319-2 & 130315-2 Forensic Use Only
    Neogen Corporation 944 Nandino Blvd., Lexington KY 40511 USA 800/477-8201 USA/Canada | 859/254-1221 Fax: 859/255-5532 | E-mail: inform@neogen.com | Web: www.neogen.com/Toxicology COCAINE/BENZOYLECGONINE-2 ELISA KIT INSTRUCTIONS PRODUCT #130319-2 & 130315-2 FORENSIC USE ONLY INTENDED USE: For the determination of trace quantities of Cocaine, Benzoylecgonine and/or other metabolites in human urine, blood, oral fluid. DESCRIPTION Neogen Corporation’s Cocaine/Benzoylecgonine-2 ELISA (Enzyme-Linked ImmunoSorbent Assay) test kit is a qualitative one-step kit designed for use as a screening device for the detection of drugs and/or their metabolites. The kit was designed for screening purposes and is intended for forensic use only. It is recommended that all suspect samples be confirmed by a quantitative method such as gas chromatography/mass spectrometry (GC/MS). ASSAY PRINCIPLES Neogen Corporation’s test kit operates on the basis of competition between the drug or its metabolite in the sample and the drug-enzyme conjugate for a limited number of antibody binding sites. First, the sample or control is added to the microplate. Next, the diluted drug-enzyme conjugate is added and the mixture is incubated at room temperature. During this incubation, the drug in the sample or the drug-enzyme conjugate binds to antibody immobilized in the microplate wells. After incubation, the plate is washed to remove any unbound sample or drug-enzyme conjugate. The presence of bound drug-enzyme conjugate is recognized by the addition of K-Blue Substrate (TMB). After a 30 minute substrate incubation, the reaction is halted with the addition of an acid stop.
    [Show full text]
  • Fate and Removal of Emerging Contaminants in Water and Wastewater Treatment Plants
    FATE AND REMOVAL OF EMERGING CONTAMINANTS IN WATER AND WASTEWATER TREATMENT PLANTS Faculty of Industrial Engineering Department of Civil, Constructional and Environmental Engineering Ph.D. School of Civil Engineering and Architecture Ph.D. Course in Environmental and Hydraulic Engineering - XXXII Cycle Ph.D. student Ing. Camilla Di Marcantonio Supervisor Co-Supervisor Prof. Agostina Chiavola Prof. Maria Rosaria Boni Abstract Abstract Organic MicroPollutants (OMPs) – also called Emerging Contaminants or Contaminants of Emerging Concern – include a wide number of chemicals belonging to different classes, e.g. pharmaceuticals and personal care products (PPCPs), drugs of abuse and their metabolites, steroids and hormones, endocrine- disrupting compounds, surfactants, perfluorinated compounds, phosphoric ester flame retardants, industrial additives and agents, siloxanes, artificial sweeteners, and gasoline additives (Barbosa et al., 2016; Bletsou et al., 2015; Chiavola et al., 2019). In the last two decades, increasing attention has been dedicated to OMPs, as a matter of high risk for public health and environment. (Naidu et al., 2016; Rodriguez-Narvaez et al., 2017; Thomaidi et al., 2016; Vilardi et al., 2017). OMPs are characterized by low environmental concentrations (about ng/L or µg/L), high toxicity, very low biodegradability and resistance to degradation and to conventional treatments. Consequently, they tend to be bioaccumulated in aquatic environments, and to enter the food chain through agriculture products and drinking water (Clarke and Smith, 2011). Measurement of OMPs in the aquatic medium became possible only in the last 20 years, thanks to the improvement of sensitivity and accuracy of the analytical methods; among the different methods, liquid chromatography coupled with high-resolution tandem mass spectrometry (LC-HRMS/MS) is increasingly applied for the analysis of some known and unknown emerging contaminants in water.
    [Show full text]
  • Screening Colour Test and Specific Colour Tests for the Detection of Methylendioxyamphetamine and Amphetamine Type Stimulants
    SCIENTIFIC AND TECHNICAL NOTES SCITEC 16 2009 Screening Colour Test and Specific Colour Tests for the Detection of Methylendioxyamphetamine and Amphetamine Type Stimulants Laboratory and Scientific Section, Division of Policy Analysis 1. Introduction The term amphetamine type stimulants (ATS) refer to a range of drugs mostly derived from the phenethylamines. Amphetamines are central nervous system (CNS) stimulants that were first synthesised more than a century ago for medical applications, but are currently mostly found on illicit drug markets. Globally, ATS use occurs in a range of contexts, and for a variety of purposes. Both recreational and occupational reasons may determine initial use; and use may occur in public settings (e.g., nightclubs), private parties, work environments or as sex aids. In this respect, ATS have demonstrated their attractiveness in a very wide range of situations that seem to differ across countries. ATS are used recreationally to experience the drug’s effects of increased sociability, loss of inhibitions, a sense of escape, or to enhance sexual encounters30‐34. In many high income countries, users typically have a history of other drug use and may use other substances in combination with M/A35‐38. M/A is sometimes used in occupational settings to sustain long work hours and to increase energy and productivity. Examples of this include use by jade‐mine workers in Myanmar, sex workers in Cambodia (Chouvy & Meissonnier, 2004), truck drivers73 159‐161 and even pilots in armed forces, where it has been provided by Governments (Emonson & Vanderbeek, 1995). Amphetamine (AMPT) and methamphetamine (MAMPT) both increase the release of dopamine, noradrenalin, adrenaline and serotonin (Seiden, Sobol, & Ricaurte, 1993; World Health Organization, 2004), stimulate the central nervous system, and have a range of effects including increased energy, feelings of euphoria, decreased appetite, elevated blood pressure and increased heart rate.
    [Show full text]
  • Staging Category Base Rate Article Description HS Heading/ Subheading D
    HS Heading/ SubheadingArticle description Base Rate Staging Category 280110000 - Chlorine 30% D 280120000 - Iodine 10% B 280130000 - Fluorine; bromine 5% A Sulphur, sublimed or precipitated; colloidal 280200000 sulphur. 5% A Carbon (carbon blacks and other forms of 280300000 carbon not elsewhere specified or included). 5% A 280410000 - Hydrogen 10% B 280421000 -- Argon 5% A 280429100 --- Neon 5% A 280429200 --- Helium 5% A 280429900 --- Other 10% B 280430000 - Nitrogen 30% D 280440000 - Oxygen : 30% D 280450000 - Boron; tellurium 10% B -- Containing by weight not less than 99.99 % of 280461000 silicon 10% B 280469000 -- Other 10% B 280470000 - Phosphorus 5% A 280480000 - Arsenic 10% B 280490000 - Selenium 5% A 280511000 -- Sodium 5% A 280519000 -- Other 5% A 280521000 -- Calcium 5% A 280522000 -- Strontium and barium 5% A - Rare-earth metals, scandium and yttrium, 280530000 whether or not intermixed or interalloyed 5% A 280540000 - Mercury 5% A 280610000 - Hydrogen chloride (hydrochloric acid) 30% D 280620000 - Chlorosulphuric acid 5% A 280700000 Sulphuric acid; oleum. 5% A 280800000 Nitric acid; sulphonitric acids. 5% A 280910000 - Diphosphorus pentaoxide 5% A 280920000 - Phosphoric acid and polyphosphoric acids 5% A 281000000 Oxides of boron; boric acids. 5% A 281111000 -- Hydrogen fluoride (hydrofluoric acid) 5% A 281119100 --- Hydrogen cyanide 5% A 281119900 --- Other 5% A 281121000 -- Carbon dioxide 30% D 281122000 -- Silicon dioxide 5% A 281123000 -- Sulphur dioxide 10% B 281129000 -- Other 5% A 281210100 -- Arsenic trichloride 5%
    [Show full text]
  • 2021 Equine Prohibited Substances List
    2021 Equine Prohibited Substances List . Prohibited Substances include any other substance with a similar chemical structure or similar biological effect(s). Prohibited Substances that are identified as Specified Substances in the List below should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by Horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance. LISTED AS SUBSTANCE ACTIVITY BANNED 1-androsterone Anabolic BANNED 3β-Hydroxy-5α-androstan-17-one Anabolic BANNED 4-chlorometatandienone Anabolic BANNED 5α-Androst-2-ene-17one Anabolic BANNED 5α-Androstane-3α, 17α-diol Anabolic BANNED 5α-Androstane-3α, 17β-diol Anabolic BANNED 5α-Androstane-3β, 17α-diol Anabolic BANNED 5α-Androstane-3β, 17β-diol Anabolic BANNED 5β-Androstane-3α, 17β-diol Anabolic BANNED 7α-Hydroxy-DHEA Anabolic BANNED 7β-Hydroxy-DHEA Anabolic BANNED 7-Keto-DHEA Anabolic CONTROLLED 17-Alpha-Hydroxy Progesterone Hormone FEMALES BANNED 17-Alpha-Hydroxy Progesterone Anabolic MALES BANNED 19-Norandrosterone Anabolic BANNED 19-Noretiocholanolone Anabolic BANNED 20-Hydroxyecdysone Anabolic BANNED Δ1-Testosterone Anabolic BANNED Acebutolol Beta blocker BANNED Acefylline Bronchodilator BANNED Acemetacin Non-steroidal anti-inflammatory drug BANNED Acenocoumarol Anticoagulant CONTROLLED Acepromazine Sedative BANNED Acetanilid Analgesic/antipyretic CONTROLLED Acetazolamide Carbonic Anhydrase Inhibitor BANNED Acetohexamide Pancreatic stimulant CONTROLLED Acetominophen (Paracetamol) Analgesic BANNED Acetophenazine Antipsychotic BANNED Acetophenetidin (Phenacetin) Analgesic BANNED Acetylmorphine Narcotic BANNED Adinazolam Anxiolytic BANNED Adiphenine Antispasmodic BANNED Adrafinil Stimulant 1 December 2020, Lausanne, Switzerland 2021 Equine Prohibited Substances List . Prohibited Substances include any other substance with a similar chemical structure or similar biological effect(s).
    [Show full text]
  • Discrimination Between Chewing of Coca Leaves Or Drinking Of
    Forensic Science International 297 (2019) 171–176 Contents lists available at ScienceDirect Forensic Science International journal homepage: www.elsevier.com/locate/forsciint Discrimination between chewing of coca leaves or drinking of coca tea and smoking of “paco” (coca paste) by hair analysis. A preliminary study of possibilities and limitations a b b, b b b N.C. Rubio , F. Krumbiegel , F. Pragst *, D. Thurmann , A. Nagel , E. Zytowski , c c c M. Aranguren , J.C. Gorlelo , N. Poliansky a Toxicology Laboratory, Patagonia, Argentina b Institute of Legal Medicine, Charité Berlin, Germany c Fundación Convivir, Buenos Aires, Argentina A R T I C L E I N F O A B S T R A C T Article history: Background: Hair analysis is a suitable way to discriminate between coca chewers and consumers of Received 2 January 2019 manufactured cocaine using the coca alkaloids hygrine (HYG) and cuscohygrine (CUS) as markers. In the Received in revised form 19 January 2019 present preliminary study it was examined whether CUS and HYG can be detected in hair of occasional Accepted 24 January 2019 and moderate coca chewers or coca tea drinkers, whether CUS and HYG appear in hair of PACO consumers Available online 5 February 2019 (smoking coca paste waste), and whether anhydroecgonine methyl ester (AEME) is a useful cocaine smoking marker in this context. Keywords: Method: Three groups were included: 10 volunteers from Buenos Aires with occasional or moderate Anhydroecgonine methyl ester chewing of coca leaves or drinking coca tea, 20 Argentinean PACO smokers and 8 German cocaine users. Chewing coca leaves – – Cocaine The hair samples (1 4 segments) were analyzed by a validated LC MS/MS method for cocaine (COC), Hygrine norcocaine (NC), benzoylecgonine (BE), ecgonine methyl ester (EME), cocaethylene (CE), cinnamoylco- Cuscohygrine caine (CIN), tropacocaine (TRO), AEME, CUS and HYG.
    [Show full text]
  • Drug Screen Listing
    DRUG SCREEN LISTING The following are detected by a general urine drug screen. Abacavir Acebutolol Acetaminophen Acetohexamide Acyclovir Alprazolam Alprazolam metabolite (alpha-Hydroxyalprazolam) Alprenolol Amantadine Ambroxol Amiloride Amiodarone Amitriptyline Amlodipine Amobarbital as BAR Amoxapine Amphetamine Aprobarbital as BAR Aripiprazole Aripiprazole metabolite (dehydro-aripiprazole) Atenolol Atomoxetine Atorvastatin Atropine Baclofen Barbital as BAR Bendiocarb Benzocaine Benztropine Betaxolol Bisoprolol Bromazepam Bromocriptine Brompheniramine Bupivacaine Buprenorphine Buprenorphine metabolite (norbuprenorphine) Bupropion Buspirone Butabarbital as BAR Butalbital as BAR BZP (1-benzylpiperazine) Caffeine Captopril Carbamazepine Carbamazepine metabolite (10,11-dihydro-10,11- Page 1 of 13 dihydroxycarbamazepine) Carbamazepine metabolite (carbamazepine-10,11-epoxide) Carisoprodol Carvedilol Cathinone Cetirizine Chlordiazepoxide Chlordiazepoxide metabolite (norchlordiazepoxide) Chloroquine Chlorpheniramine Chlorpromazine Chlorpropamide Chlorprothixene Cilazapril Cimetidine Citalopram Citalopram metabolite (desmethylcitalopram) Clenbuterol Clobazam Clobazam metabolite (desmethylclobazam) Clomipramine Clomipramine metabolite (desmethylclomipramine) Clonazepam Clonazepam metabolite (7-Aminoclonazepam) Clonidine Clozapine Clozapine metabolite (clozapine-N-oxide) Clozapine metabolite (norclozapine) Cocaine Cocaine metabolite (benzoylecgonine) Cocaine metabolite (cocaethylene) Cocaine metabolite (ecgoninemethylester) Cocaine metabolite (ethylecgonine)
    [Show full text]
  • Idaho State Police Forensic Laboratory Training Manual Cocaine
    Idaho State Police Forensic Laboratory Training Manual Cocaine 1.0.0 HISTORY Archaeological artifacts show that the use of coca was widely accepted in ancient cultures of South American Indians. Paintings on pottery, ornaments depicting pictures and symbols of the coca bush and its leaves, as well as sculptured wood and metal objects dating as far back as 3000 BC on the coast of Ecuador indicate the use of coca in both civil and religious rituals. Relatively recent studies of the antiquity of the use and cultivation of coca indicate that the Servicescoca plant is native to the eastern Andes Mountains. Until this day, the natives in the area continue the custom of chewing coca. A French chemist, Angelo Mariani, introduced Europe to the coca leaf by importing tons of coca leaves and using an extract from them in many products such as his “Coca Wine.” Cocaine, as obtainedForensic fromCopy the coca leaves, was first discovered by Gaedecke in 1855 and rediscovered by Niemann in 1859, at which time he gave the compound the name cocaine. The local anesthetic properties of cocaine were demonstrated first by Wohler in 1860; however, it was not used medically until 1864 as a topical anestheticPolice in the eye. Internet 2.0.0 TAXONOMY DOCUMENT The French botanist JosephState de Jussieu made the first taxonomical reference to coca1 in 1750. He assigned the plants to the genus Erythroxylum. Later, Lamarck, another French botanist, published six new species, including the famous ErythroxylumIdaho coca Lamarck, in 1786. Today, the full taxonomical classificationof is: CATEGORYUncontrolled TAXON OBSOLETE Division (phylum) Spermatophyta Class Dicotyledons (shrubs and trees) PropertyOrder Geraniales Family Erythroxylaceae Genus Erythroxylum Species One Erythroxylum coca Lamarck 1Note that other literature sources seem to credit Patrick Brown as the founder of the genus Erythroxylum (in 1756).
    [Show full text]